Amgen strives to deliver successful treatments to patients. This goes well beyond the development of innovative medicines and preventive therapies. We provide services, advice and new solutions that contribute to a better and more efficient healthcare system. We do this in the following fields:

ONCOLOGY AND HEMATOLOGY

  • Particular types of cancer involving tumor formation, such as breast cancer, colorectal cancer, prostate cancer, lung cancer
  • Hematological types of cancer (cancers of particular blood cells) such as Acute Lymphoblastic Leukemia (ALL) and Multiple Myeloma (MM)
  • Immune Mediated Thrombocytopenia (ITP) - a disease whereby the immune system destroys the body’s own platelets
  • A shortage of white or red blood cells due to chemotherapy

NEPHROLOGY DISEASES

  • Severe renal failure in the predialysis or dialysis stage

BONE DISEASES

  • Osteoporosis - in post-menopausal women and also in men
  • Bone complications caused by Bone Lesions or Bone metastases(dissemination of cancer in the bone) in patients with advanced cancer.

CARDIOVASCULAR DISEASES

  • Elevated LDL cholesterol (the bad cholesterol) in patients with a very high risk of cardiovascular diseases, for whom currently available drugs have not yet succeeded in lowering the LDL cholesterol level sufficiently

INFLAMMATORY DISEASES

  • Rheumatic diseases such as rheumatoid arthritis
  • Bowel disorders such as Crohn's disease and Colitis Ulcerosa
  • Skin diseases such as psoriasis
  • Eye diseases such as uveitis

RARE DISEASE

  • A medicine for the treatment of thyroid eye disease



In addition, Amgen has developed a range of activities and services that contribute to sustainable care.

science-page-call-out
science-page-call-out-mobile

Want To Know More About What We Are Working On?

For information on the drugs that are in development, we invite you to visit our pipeline